IL143502A0 - Pharmaceutical formulations in hydroxypropylmethylcellulose capsules - Google Patents

Pharmaceutical formulations in hydroxypropylmethylcellulose capsules

Info

Publication number
IL143502A0
IL143502A0 IL14350200A IL14350200A IL143502A0 IL 143502 A0 IL143502 A0 IL 143502A0 IL 14350200 A IL14350200 A IL 14350200A IL 14350200 A IL14350200 A IL 14350200A IL 143502 A0 IL143502 A0 IL 143502A0
Authority
IL
Israel
Prior art keywords
pharmaceutical formulations
hydroxypropylmethylcellulose capsules
hydroxypropylmethylcellulose
capsules
formulations
Prior art date
Application number
IL14350200A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of IL143502A0 publication Critical patent/IL143502A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14350200A 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules IL143502A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9918885.6A GB9918885D0 (en) 1999-08-10 1999-08-10 Pharmaceutical formulations in hydroxypropymethycellulose capsules
PCT/EP2000/006590 WO2001010443A1 (en) 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules

Publications (1)

Publication Number Publication Date
IL143502A0 true IL143502A0 (en) 2002-04-21

Family

ID=10858930

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14350200A IL143502A0 (en) 1999-08-10 2000-07-11 Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
IL143502A IL143502A (en) 1999-08-10 2001-05-31 Pharmaceutical formulations comprising camptothecin analogues in hydroxypropylmethylcellulose capsules

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143502A IL143502A (en) 1999-08-10 2001-05-31 Pharmaceutical formulations comprising camptothecin analogues in hydroxypropylmethylcellulose capsules

Country Status (18)

Country Link
US (1) US6569452B1 (es)
EP (1) EP1126851B1 (es)
CN (1) CN1245976C (es)
AR (1) AR025060A1 (es)
AT (1) ATE262905T1 (es)
AU (1) AU6158200A (es)
CA (1) CA2354039C (es)
CO (1) CO5200854A1 (es)
CZ (1) CZ293749B6 (es)
DE (1) DE60009442D1 (es)
EA (1) EA200100568A1 (es)
GB (1) GB9918885D0 (es)
HK (1) HK1040930B (es)
HU (1) HUP0104476A3 (es)
IL (2) IL143502A0 (es)
NO (1) NO319712B1 (es)
PE (1) PE20010407A1 (es)
WO (1) WO2001010443A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
CN1316970C (zh) * 2002-11-14 2007-05-23 武汉华中科大纳米药业有限公司 一种羟喜树碱固体分散物及其制剂
JP2005183361A (ja) * 2003-10-03 2005-07-07 Ngk Insulators Ltd 電子放出素子、電子放出装置、ディスプレイ及び光源
US20050208146A1 (en) * 2003-10-30 2005-09-22 Pfizer Inc Novel dosage and administration method for oral camptosar
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
GB0526419D0 (en) * 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
CN101516346B (zh) * 2006-09-26 2012-05-23 株式会社三养社 水不溶性喜树碱衍生物的亚微粒纳米颗粒及其制备方法
CA2844367C (en) * 2011-06-24 2016-02-16 Acenda Pharma, Inc. Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
CN103110605A (zh) * 2011-11-17 2013-05-22 天士力制药集团股份有限公司 一种热熔胶囊制剂及其制备方法
ES2680444T3 (es) * 2014-01-17 2018-09-07 Oncoral Pharma Aps Forma de dosificación oral sólida de irinotecán para el tratamiento del cáncer
CN105287427B (zh) * 2015-10-20 2017-04-19 沈阳红旗制药有限公司 一种利福平半固体胶囊及其制备方法
KR102066402B1 (ko) * 2017-12-22 2020-01-15 대화제약 주식회사 이리노테칸 또는 그의 약제학적으로 허용가능한 염을 포함하는 경구투여용 약제학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
DE69531611T2 (de) * 1994-04-28 2004-02-26 Bionumerik Pharmaceuticals, Inc., San Antonio Lactone-stabile camptothecin oder 7 - ethyl camptothecin - formulierung in dimethylisosorbid oder dimethylacetamid
US5597829A (en) 1994-05-09 1997-01-28 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of camptothecin and methods for uses thereof
US5756123A (en) * 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
KR20000029784A (ko) * 1996-08-02 2000-05-25 나까도미 히로다카 경구제제용캡슐과경구캡슐제제
AR013261A1 (es) * 1997-08-01 2000-12-13 Smithkline Beecham Corp Formulaciones farmaceuticas para analogos de camptotecina en capsula de gelatina

Also Published As

Publication number Publication date
CN1245976C (zh) 2006-03-22
HK1040930A1 (en) 2002-06-28
NO20013205L (no) 2001-06-26
EP1126851B1 (en) 2004-03-31
CZ20012089A3 (cs) 2001-10-17
US6569452B1 (en) 2003-05-27
IL143502A (en) 2006-12-10
CO5200854A1 (es) 2002-09-27
CN1327387A (zh) 2001-12-19
HUP0104476A3 (en) 2004-05-28
ATE262905T1 (de) 2004-04-15
EA200100568A1 (ru) 2001-10-22
AU6158200A (en) 2001-03-05
HUP0104476A2 (hu) 2002-03-28
PE20010407A1 (es) 2001-03-28
EP1126851A1 (en) 2001-08-29
HK1040930B (zh) 2006-10-27
WO2001010443A1 (en) 2001-02-15
AR025060A1 (es) 2002-11-06
DE60009442D1 (de) 2004-05-06
CA2354039C (en) 2008-09-23
CA2354039A1 (en) 2001-02-15
NO20013205D0 (no) 2001-06-26
NO319712B1 (no) 2005-09-05
GB9918885D0 (en) 1999-10-13
CZ293749B6 (cs) 2004-07-14

Similar Documents

Publication Publication Date Title
IL147756A0 (en) Preserved pharmaceutical formulations
HK1045804A1 (en) Improved pharmaceutical formulations comprising ritonavir
IL146632A0 (en) Pharmaceutical tablets
HUP0203585A3 (en) Pharmaceutical combinations
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
HK1040930A1 (en) Pharmaceutical formulations in hydroxypropylmethylcellulose capsules
HK1046140A1 (zh) 固體藥劑
EP1173216A4 (en) PHARMACEUTICAL FORMULATIONS
IL146341A0 (en) Pharmaceutical complex
GB9909154D0 (en) Pharmaceutical formulation
EP1221941A4 (en) PHARMACEUTICAL FORMULATIONS POWDER
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
GB9926251D0 (en) Pharmaceutical formulation
IL132666A0 (en) Phytoestrogenic pharmaceutical preparations
GB9905983D0 (en) Pharmaceutical formulations
GB9911826D0 (en) Pharmaceutical formulations
GB9903177D0 (en) Pharmaceutical formulations
HU9902398D0 (en) Pharmaceutical preparation
CA88762S (en) Pharmaceutical tablet
GB9910636D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9921396D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
HP Change in proprietorship
KB Patent renewed
FF Patent granted